These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24297672)

  • 1. Vasopressin as an adjunct therapy for pulmonary hypertension: a case report.
    Malikiwi A; Sasi A; Tan K; Sehgal A
    Eur J Pediatr; 2014 Dec; 173(12):1651-4. PubMed ID: 24297672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin as a rescue therapy for refractory pulmonary hypertension in neonates: case series.
    Mohamed A; Nasef N; Shah V; McNamara PJ
    Pediatr Crit Care Med; 2014 Feb; 15(2):148-54. PubMed ID: 24141655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Levosimendan and Vasopressin in New-Onset Acute Pulmonary Hypertension After Weaning from Cardiopulmonary Bypass.
    Poidinger B; Kotzinger O; Rützler K; Kleinsasser A; Zierer A; Knotzer H
    J Cardiothorac Vasc Anesth; 2019 Feb; 33(2):328-333. PubMed ID: 30122612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin versus dopamine for treatment of hypotension in extremely low birth weight infants: a randomized, blinded pilot study.
    Rios DR; Kaiser JR
    J Pediatr; 2015 Apr; 166(4):850-5. PubMed ID: 25641242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravenous arginine vasopressin for two pediatric cases of pulmonary hypertension after congenital heart surgery].
    Nagamine Y; Hara M
    Masui; 2012 Oct; 61(10):1112-6. PubMed ID: 23157099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose vasopressin infusion can be an alternative in treating patients with refractory septic shock combined with chronic pulmonary hypertension--a case report.
    Wang HJ; Wong CS; Chiang CY; Yeh CC; Cherng CH; Ho ST; Wu CT
    Acta Anaesthesiol Sin; 2003 Jun; 41(2):77-80. PubMed ID: 12934421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease.
    Lee JE; Hillier SC; Knoderer CA
    J Intensive Care Med; 2008; 23(5):329-34. PubMed ID: 18701525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric Oxide Story.
    Zapol WM
    Anesthesiology; 2019 Mar; 130(3):435-440. PubMed ID: 30664059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized study of inhaled prostacyclin versus nitric oxide in patients with residual pulmonary hypertension after pulmonary endarterectomy.
    Abe S; Ishida K; Masuda M; Ueda H; Kohno H; Matsuura K; Tamura Y; Watanabe M; Matsumiya G
    Gen Thorac Cardiovasc Surg; 2017 Mar; 65(3):153-159. PubMed ID: 27783213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension.
    Kinsella JP; Toews WH; Henry D; Abman SH
    J Pediatr; 1993 May; 122(5 Pt 1):803-6. PubMed ID: 8496766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute pulmonary hypertension in infants and children: cGMP-related drugs.
    Fraisse A; Wessel DL
    Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S37-40. PubMed ID: 20216161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac function and its evolution with pulmonary vasodilator therapy: a myocardial deformation study.
    Sehgal A; Ibrahim M; Tan K
    Echocardiography; 2014 Jul; 31(6):E185-8. PubMed ID: 24665999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide and related therapies.
    Barr FE; Macrae D
    Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S30-6. PubMed ID: 20216160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin in newborns with refractory acute pulmonary hypertension.
    Ouellet S; Drolet C; Morissette G; Pellerin A; Hébert A
    Pediatr Res; 2024 May; 95(6):1572-1577. PubMed ID: 38212386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose response to inhaled nitric oxide in pediatric patients with pulmonary hypertension and acute respiratory distress syndrome.
    Nakagawa TA; Morris A; Gomez RJ; Johnston SJ; Sharkey PT; Zaritsky AL
    J Pediatr; 1997 Jul; 131(1 Pt 1):63-9. PubMed ID: 9255193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term survival rate of catecholamine-resistant septic shock in Japanese patients who received vasopressin therapy.
    Sawa N; Ubara Y; Katori H; Hoshino J; Suwabe T; Takemoto F; Uchida N; Masuoka K; Wake A; Taniguchi S; Takaichi K
    Clin Nephrol; 2009 Aug; 72(2):129-36. PubMed ID: 19640370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension.
    Tayama E; Ueda T; Shojima T; Akasu K; Oda T; Fukunaga S; Akashi H; Aoyagi S
    Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):715-9. PubMed ID: 17704123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxyhemoglobin formation secondary to nitric oxide therapy in the setting of interstitial lung disease and pulmonary hypertension.
    Ruisi P; Ruisi M
    South Med J; 2011 Jan; 104(1):46-8. PubMed ID: 21079530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhalation therapy with nitric oxide in pulmonary hypertension: Comparison of preterm infants versus newborn infants].
    Schmölzer G; Urlesberger B; Reiterer F; Haim M; Kutschera J; Resch B; Müller W
    Klin Padiatr; 2003; 215(5):257-61. PubMed ID: 14520586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide and prostacyclin lower suprasystemic pulmonary hypertension after cardiopulmonary bypass.
    Schranz D; Huth R; Wippermann CF; Ritzerfeld S; Schmitt FX; Oelert H
    Eur J Pediatr; 1993 Oct; 152(10):793-6. PubMed ID: 8223778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.